As well as curcumin, imatinib, and thalidomide have all been shown to inhibit melanoma VM, concomitant with decreases in EPHA2, VE-cadherin, PI3K, VEGF, HIF-1, MMP-2, and MMP-9 expression and/or activity. The gene discussed is MMP2; the disease is melanoma.